Clinical trials: Capillary Leak Syndrome
Hairy Cell Leukemia
US Post-Marketing Safety Study of Moxetumomab Pasudotox-tdfk (LUMOXITI)
This study is being conducted to satisfy a post-marketing requirement (PMR) to provide evidence characterizing 1) the safety of moxetumomab pasudotox-tdfk in patients who are 65 years of age and older and/or 2) the safety of…
- Trial name
- PROXY (NCT04125290)
- Where
- 2 sites in United States
- Volunteers
- 2 people
- Sponsor
- AstraZeneca
Systemic Capillary Leak Syndrome
Studies in the Pathogenesis of Systemic Capillary Leak Syndrome
Background: Systemic Capillary Leak Syndrome (SCLS) is a disorder of unknown cause characterized by episodes of life-threatening drop in blood pressure and leakage of fluids into tissues.
- Trial name
- NCT00936325
- Where
- United States
- Volunteers
- 152 people
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)